CDK4/6 and diffuse intrinsic pontine glioma - Evaluate at diagnosis?

Oren J. Becher

doi:10.1016/j.ebiom.2019.05.020

CDK4/6 and diffuse intrinsic pontine glioma - Evaluate at diagnosis?

Oren J. Becher

Research output: Contribution to journal › Comment/debate

6 Scopus citations

Original language	English
Pages (from-to)	16-17
Number of pages	2
Journal	eBioMedicine
Volume	44
DOIs	https://doi.org/10.1016/j.ebiom.2019.05.020
State	Published - Jun 2019
Externally published	Yes

Access to Document

10.1016/j.ebiom.2019.05.020

Cite this

@article{0e637e009e234d7a9affefb7b995e8c2,

title = "CDK4/6 and diffuse intrinsic pontine glioma - Evaluate at diagnosis?",

author = "Becher, \{Oren J.\}",

note = "Funding Information: The author declares that his laboratory receives funding from the Andrew McDonough B+ Foundation to evaluate the efficacy of CDK4/6 inhibition in combination with MEK inhibition in preclinical models of diffuse intrinsic pontine glioma.",

year = "2019",

month = jun,

doi = "10.1016/j.ebiom.2019.05.020",

language = "English",

volume = "44",

pages = "16--17",

journal = "eBioMedicine",